3 Stocks Pushing The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 69 points (-0.4%) at 16,384 as of Monday, March 10, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 999 issues advancing vs. 1,928 declining with 160 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 3.3%, DexCom ( DXCM), down 3.1%, Laboratory Corporation of America Holdings ( LH), down 2.4%, Brookdale Senior Living ( BKD), down 2.3% and Alere ( ALR), down 2.3%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Globus Medical ( GMED) is one of the companies pushing the Health Services industry higher today. As of noon trading, Globus Medical is up $0.54 (2.1%) to $25.84 on light volume. Thus far, 175,003 shares of Globus Medical exchanged hands as compared to its average daily volume of 698,100 shares. The stock has ranged in price between $25.30-$25.88 after having opened the day at $25.35 as compared to the previous trading day's close of $25.30.

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. Globus Medical has a market cap of $2.4 billion and is part of the health care sector. Shares are up 27.3% year-to-date as of the close of trading on Friday. Currently there are 6 analysts who rate Globus Medical a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Globus Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Globus Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Catamaran ( CTRX) is up $1.10 (2.5%) to $45.46 on heavy volume. Thus far, 2.1 million shares of Catamaran exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $44.13-$45.52 after having opened the day at $44.53 as compared to the previous trading day's close of $44.36.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $9.2 billion and is part of the health care sector. Shares are down 6.0% year-to-date as of the close of trading on Friday. Currently there are 12 analysts who rate Catamaran a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Edwards Lifesciences Corporation ( EW) is up $0.90 (1.2%) to $72.97 on average volume. Thus far, 827,515 shares of Edwards Lifesciences Corporation exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $72.61-$73.35 after having opened the day at $73.34 as compared to the previous trading day's close of $72.07.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation has a market cap of $7.8 billion and is part of the health care sector. Shares are up 9.9% year-to-date as of the close of trading on Friday. Currently there are 6 analysts who rate Edwards Lifesciences Corporation a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow, unimpressive growth in net income and a generally disappointing performance in the stock itself. Get the full Edwards Lifesciences Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet